Log In
BCIQ
Print this Print this
 

LC350189

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia/gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today